◆ Mixed
How new safety evidence is boosting India’s expanding Ashwagandha market
29 Sept 2026 · Business Today Mkts
Government-backed 24-week trial of 1,200 adults finds no liver or kidney injury from a standardised root extract.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- This is a market-wide development — its reach goes beyond any single stock.